hiv-infections

Documents about hiv-infections

• Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults#451502ClinicalTrials.gov
• Evaluating the Safety and Immunogenicity of an HIV-1 gp41 MPER-656 Liposome Vaccine in Healthy, HIV-uninfected Adult Participants#471496ClinicalTrials.gov
• ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects#807202ClinicalTrials.gov
• Daclizumab to Treat HIV-Infected Patients#830283ClinicalTrials.gov
• Integrating Family Planning Services Into HIV Care and Treatment in Nyanza Province, Kenya#844376ClinicalTrials.gov
• Use of HIV Self-Test Kits to Increase Identification of HIV-Infected Individuals and Their Partners#851434ClinicalTrials.gov
• Safety and Acceptability of PRO 2000 Vaginal Gel in HIV Uninfected Women in India#860991ClinicalTrials.gov
• Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women#870981ClinicalTrials.gov
• Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients#872836ClinicalTrials.gov
• Immune Response to Influenza Vaccine in HIV-Infected Individuals#873992ClinicalTrials.gov
• Vedolizumab Treatment in HIV-Infected Subjects Without Previous Antiretroviral Therapy#881603ClinicalTrials.gov
• HIV Prevention Counseling for Men Who Have Sex With Men#882224ClinicalTrials.gov
• A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs#884958ClinicalTrials.gov
• Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate#885536ClinicalTrials.gov
• ALVAC-HIV vCP1452 Alone and Combined With MN rgp120#853256ClinicalTrials.gov
• Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients#870265ClinicalTrials.gov
• A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers#463758ClinicalTrials.gov
• Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection#828893ClinicalTrials.gov
• Exploring Long-term Risks and STI Prevalence in Pre-Exposure Prophylaxis Users in Gironde, France#833300ClinicalTrials.gov
• The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms#834000ClinicalTrials.gov
• Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)#857596ClinicalTrials.gov
• A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections#803812ClinicalTrials.gov
• Improving Perinatal Outcomes Among Kenyan Pregnant Women With an Integrated STI Testing Model#121414ClinicalTrials.gov
• Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults#172389ClinicalTrials.gov
• Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients#208268ClinicalTrials.gov
• Influence of the intracellular environment on HIV-1 replication and its modulation by innate cytokines#228155Ora Oxford University Research
• Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women#261340ClinicalTrials.gov
• A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine#432931ClinicalTrials.gov
• Effect of Steady State TPV/r on Intracellular Concentrations of Zidovudine and Carbovir for Patients With HIV#811753ClinicalTrials.gov
• The PrEP (Pre-exposure Prophylaxis) SMART Study#840881ClinicalTrials.gov
• Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen#841789ClinicalTrials.gov
• Pharmacokinetics and Efficacy of Multiple Dosing of Lipovirtide for Injection in HIV-infected Patients#850144ClinicalTrials.gov
• Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)#855403ClinicalTrials.gov
• China Antiretroviral Treatment Adherence for Life#858485ClinicalTrials.gov
• Maraviroc Immune Recovery Study#861025ClinicalTrials.gov
• REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment#861312ClinicalTrials.gov
• Contingency Management for Cannabis Use for Persons With HIV#876297ClinicalTrials.gov
• Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis#884804ClinicalTrials.gov
• Treatment of Hepatitis C in Hemophilic Patients With HIV#891156ClinicalTrials.gov
• Assessing the Effectiveness and Feasibility of Voluntary Assisted Partner Notification Services#893764ClinicalTrials.gov
• AmbassADDOrs for Health Study#901013ClinicalTrials.gov
• Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United States#123542ClinicalTrials.gov
• Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination#426651ClinicalTrials.gov
• Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery#825054ClinicalTrials.gov
• Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults#825985ClinicalTrials.gov
• A Pilot Study of an Online HIV Stigma Training for Nursing Students in Iran#836317ClinicalTrials.gov
• A Trial of Vitamins and HAART in HIV Disease Progression#838942ClinicalTrials.gov
• Community Mobilization, Mobile Testing, Same-Day Results, and Post-Test Support for HIV in Sub-Saharan Africa and Thailand#867346ClinicalTrials.gov
• Young Men's Health Project Targeting HIV Risk Reduction and Substance Abuse#887084ClinicalTrials.gov
• Reducing HIV Risk Among Episodic Substance Using Men Who Have Sex With Men (SUMSM)#889528ClinicalTrials.gov